ImmunosuppressionImmunosuppressive AgentsTacrolimusCyclosporineImmune ToleranceGraft RejectionKidney TransplantationAzathioprineMycophenolic AcidTumor Necrosis Factor-alphaGraft SurvivalTumor Markers, BiologicalTumor BurdenAntilymphocyte SerumCell Line, TumorTransplantation, HomologousT-LymphocytesMice, Inbred BALB CLiver TransplantationImmunocompromised HostMice, Inbred C57BLCyclosporinsTreatment OutcomeNeoplasms, ExperimentalTime FactorsLymphocyte ActivationOrgan TransplantationCalcineurinSirolimusTumor MicroenvironmentWilms TumorSpleenAntibodies, MonoclonalTransplantation ImmunologyHeart TransplantationGenes, Tumor SuppressorRetrospective StudiesCell ProliferationBrain NeoplasmsCarcinoid TumorTumor Suppressor Protein p53T-Lymphocytes, RegulatoryTransplantation, HeterologousIslets of Langerhans TransplantationNeoplasmsCells, CulturedFlow CytometryLymphocytesPrednisolonePancreas TransplantationSkin NeoplasmsCytokinesNeuroendocrine TumorsDrug Therapy, CombinationTransplantation ToleranceTumor Suppressor ProteinsTransplantationAnemia, AplasticCyclophosphamideMammary Neoplasms, ExperimentalDisease Models, AnimalInterleukin-10MethylprednisoloneAdrenal Cortex HormonesCell DivisionInterferon-gammaImmunotherapyFollow-Up StudiesLymphoproliferative DisordersPrednisoneDendritic CellsRNA, MessengerNeoplasm MetastasisNeovascularization, PathologicBiopsyImmunity, CellularSignal TransductionAntigens, NeoplasmAntibody FormationAdenocarcinomaReverse Transcriptase Polymerase Chain ReactionIndoleamine-Pyrrole 2,3,-DioxygenaseDisease ProgressionCell LineCD4-Positive T-LymphocytesInterleukin-2Tumor Virus InfectionsTissue DonorsLiver NeoplasmsDose-Response Relationship, DrugSkin TransplantationOpportunistic InfectionsPostoperative ComplicationsRecurrenceMice, TransgenicSurvival RateImmune SystemMelanoma, ExperimentalMacrophagesMice, SCID